Zinc vs. folic acid for high homocysteine in kidney dialysis
Treatments studied
Part of Kidney & urinary clinical trials.
This trial tests whether zinc supplements can lower high homocysteine levels better than folic acid in people with chronic kidney disease who are on hemodialysis. It aims to find a simple, safe way to help protect your heart and blood vessels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have chronic kidney disease and have been on hemodialysis for at least 3 months.
- Your homocysteine level is higher than 15 micromoles per liter (a blood test measures this).
- You are not currently taking zinc or folic acid supplements.
- You do not have a condition that prevents nutrient absorption (like malabsorption).
- You are not taking certain medications or supplements that could interfere (like vitamin B12, steroids, or some antibiotics).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the balance of two minerals (copper and zinc) in people with kidney failure on dialysis, to see if their levels relate to health outcomes. It may help doctors better manage nutrition for kidney patients.
This trial tests whether controlling homocysteine levels can help people with Parkinson's disease who are taking levodopa. You may qualify if you take at least 300 mg of levodopa per day, are between 40 and 90 years old, and have no major kidney problems or uncontrolled high blood pressure.
This trial tests whether folic acid, a common vitamin, can help patients with acute kidney injury (a sudden drop in kidney function) recover while they are in the hospital. It aims to see if folic acid is safe and feasible to use for this condition.
This study tests if taking zinc supplements can improve bone health in people with sickle cell disease. It's for those with certain types of sickle cell disease (SS or S-Beta zero thalassemia) who are not on chronic transfusions or zinc supplements.
This trial tests whether closely managing potassium levels during hemodialysis can help protect the heart in patients with kidney failure who are on maintenance dialysis. It aims to reduce the risk of heart problems related to potassium swings.
This study tests whether taking fish oil supplements can improve the function of 'good' cholesterol (HDL) in people who are on regular dialysis for kidney failure. It might help reduce heart risks in dialysis patients.
Hear when a new Chronic Kidney Disease Requiring Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.